CN Patent

CN105384730A — 依帕列净的晶型及其制备方法、药物组合物和用途

Assigned to Hangzhou Pushai Pharmaceutical Technology Co Ltd · Expires 2016-03-09 · 10y expired

What this patent protects

本发明涉及依帕列净的新晶型，所述新晶型与已知晶型相比具有多种改进特性，适合药物制剂应用。本发明还涉及新晶型的制备方法、其药物组合物及其在制备用于治疗和/或预防II型糖尿病的药物中的用途。

USPTO Abstract

本发明涉及依帕列净的新晶型，所述新晶型与已知晶型相比具有多种改进特性，适合药物制剂应用。本发明还涉及新晶型的制备方法、其药物组合物及其在制备用于治疗和/或预防II型糖尿病的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105384730A
Jurisdiction
CN
Classification
—
Expires
2016-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Pushai Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.